PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 73 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $504,000 | +70.3% | 133,380 | +72.2% | 0.00% | – |
| Q2 2021 | $296,000 | +504.1% | 77,434 | +305.7% | 0.00% | – |
| Q1 2021 | $49,000 | +4.3% | 19,088 | +25.2% | 0.00% | – |
| Q2 2020 | $47,000 | +11.9% | 15,242 | -17.6% | 0.00% | – |
| Q1 2020 | $42,000 | -61.8% | 18,498 | -38.9% | 0.00% | – |
| Q4 2019 | $110,000 | -63.2% | 30,286 | -65.5% | 0.00% | – |
| Q3 2019 | $299,000 | -26.5% | 87,755 | +1.4% | 0.00% | -100.0% |
| Q2 2019 | $407,000 | +65.4% | 86,562 | +18.0% | 0.00% | – |
| Q1 2019 | $246,000 | +85.0% | 73,372 | +47.0% | 0.00% | – |
| Q4 2018 | $133,000 | -1.5% | 49,904 | +107.0% | 0.00% | – |
| Q3 2018 | $135,000 | – | 24,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |